Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| BV-2 | IC50 | 1.54 μM | Cytotoxicity against mouse BV-2 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay | [PMID: 34923430] |
| CHO | IC50 | 34.3 μM | Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits | [PMID: 23812503] |
| HEK293 | IC50 | > 200 μM | Cytotoxicity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 32388114] |
| HEK293 | IC50 | 0.009 μM | Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method | [PMID: 26471320] |
| HEK293 | IC50 | 0.01 μM | Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method | [PMID: 28242552] |
| HEK293 | IC50 | 0.016 μM | Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins | [PMID: 25418133] |
| HEK293 | IC50 | 6.2 nM | Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method | [PMID: 31304000] |
| HEK293 | IC50 | 7.5 μM | Inhibition of human recombinant BuChE expressed in HEK293 cells using S-butyrylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method | [PMID: 26471320] |
| HEK293 | IC50 | 8.2 μM | Inhibition of recombinant human BuChE expressed in HEK293 cells preincubated for 15 mins | [PMID: 25418133] |
| HepG2 | IC50 | 262727 nM | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay | [PMID: 34530383] |
| HFF | IC50 | 0.091 μM | Cytotoxicity against HFF cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay | [PMID: 32088494] |
| HT-22 | IC50 | 56.42 μM | Cytotoxicity against mouse HT-22 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay | [PMID: 34923430] |
| MCF7 | IC50 | 0.06 μM | Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay | [PMID: 32088494] |
| NIH3T3 | IC50 | 316.42 μM | Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay | [PMID: 27789142] |
| SH-SY5Y | IC50 | > 200 μM | Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 32388114] |
| SH-SY5Y | IC50 | 0.3 μM | Cytotoxicity against human SH-SY5Y cells measured after 48 hrs by MTT assay | [PMID: 32088494] |
| SH-SY5Y | IC50 | 15.54 μM | Cytotoxicity against human SH-SY5Y cells after 72 hrs by SRB assay | [PMID: 27823887] |
| SH-SY5Y | IC50 | 155 μM | Antialzheimer activity in human SH-SY5Y cells assessed as inhibition of GA-induced tau hyperphosphorylation at Ser396 residue incubated for 24 hrs by ELISA | [PMID: 36257284] |
| SH-SY5Y | IC50 | 202 μM | Antioxidant activity against okadaic acid-induced ROS generation in human SH-SY5Y cells assessed as reduction in DCF fluorescence intensity pretreated for 24 hrs followed by okadaic acid addition for 24 hrs by DCFH-DA dye based fluorescence analysis | [PMID: 36257284] |
19 records · Scroll to view more